RefCheck Maintenance Notice

On Monday, December 3, 2018, from 16:00-18:00 EST, RefCheck will be undergoing maintenance. RefCheck is the process where, during copyediting, all references are extracted from the manuscript file, parsed, matched against various databases (eg, PubMed and CrossRef), and automatically corrected. For more information on RefCheck, please visit our Knowledge Base.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 29.07.15 in Vol 4, No 3 (2015): Jul-Sep

This paper is in the following e-collection/theme issue:

Works citing "Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.4552):

(note that this is only a small subset of citations)

  1. Baye E, de Courten MP, Walker K, Ranasinha S, Earnest A, Forbes JM, de Courten B. Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial. Scientific Reports 2017;7(1)
    CrossRef
  2. de Courten B, de Courten MP, Soldatos G, Dougherty SL, Straznicky N, Schlaich M, Sourris KC, Chand V, Scheijen JL, Kingwell BA, Cooper ME, Schalkwijk CG, Walker KZ, Forbes JM. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial. The American Journal of Clinical Nutrition 2016;103(6):1426
    CrossRef
  3. Adams JN, Martelle SE, Raffield LM, Freedman BI, Langefeld CD, Hsu F, Maldjian JA, Williamson JD, Hugenschmidt CE, Carr JJ, Cox AJ, Bowden DW. Analysis of advanced glycation end products in the DHS Mind Study. Journal of Diabetes and its Complications 2016;30(2):262
    CrossRef
  4. de Vos LC, Lefrandt JD, Dullaart RP, Zeebregts CJ, Smit AJ. Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis 2016;254:291
    CrossRef